I believe they will go slow / pause enrolments in the CLX trial while they optimise the administration process.
sounds like they are well advanced on that front, although I’m not clear why the new approach is simpler than the previous method.
to the extent that it makes the therapy more commercially viable I am all for it. Especially given that this will only cause a moderate delay in the order of a months….
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.747M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.858K | 619.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 66 | 58647032 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 107164382 | 32 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| CHM (ASX) Chart |